Trial site
Central Miami Medical Institute
- 4running trials
- 7closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease5 trials
- Depression3 trials
- Bipolar disorder2 trials
- Mild cognitive impairment2 trials
- Schizophrenia1 trial
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Completed5 trials
- Active, not recruiting4 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Biohaven Pharmaceuticals, Inc.2 trials
- Novo Nordisk A/S2 trials
- Xenon Pharmaceuticals Inc.2 trials
- ACADIA Pharmaceuticals Inc.1 trial
- IGC Pharma, LLC1 trial
- and 3 more
Running trials
Active, not recruiting
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)
Active, not recruiting
Active, not recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Active, not recruiting
Closed trials
Recruiting
Completed
Completed
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)
Completed
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
Terminated
Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder
Completed
Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder
Site data: ClinicalTrials.govUpdated 18 Nov 2026